Table 3 Description of the originality and validity of tools used in surveys assessing knowledge, beliefs and attitudes of physicians towards their interaction with pharmaceutical companies
| Â | Newly developed | Previously developed, used as is | Previously developed, modified |
|---|---|---|---|
Validated | Fernandez [2] McKinney [23] Andaleeb [22] | Â | Ferrari [20] |
Non validated | Mikhael [34] Indhumati [35] Tabas [36] Loh [27] Thomson [26] Skoglund [25] De Gara [37] Evans [38] Magzoub [39] Saito [40] Alghasham [41] Ellison [42] Ross [43] Burashnikova [44] Fortuna [45] Tobin [46] Morgan [6] Brett [47] Rutledge [48] De Las Cuevas [49] Spiller [50] Jones [51] Figueiras [1] Guldal [52] Gaedeke [53] Gibbons [54] Creyer [55] Gaither [56] Gaither [57] Banks 1992 [58] Hayes [59] Stross [60] Hull [61] Evans [62] | Siddiqi [63] Macneill [24] Alssageer [64] Stoddard [65] Sara [66] | Oshikoya [67] Othman [68]a Rajan [69]a Caudill [70]a |